This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07606/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07606/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07606/identifier/chemspider/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07606/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07606/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07606
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07606 n12:DB07606
dcterms:title
6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE
adms:identifier
n4:D05 n7:20120282 n10:5327057 n11:99444077 n14:DB07606
n5:IUPAC-Name
n6:271B54A8-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B54AE-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B54AD-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B54AA-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B54AB-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B54AC-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B54A6-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B54A4-363D-11E5-9242-09173F13E4C5 n6:271B54A7-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B54A5-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B54B4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B54B5-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B54AF-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B54B0-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B54B2-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B54B1-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B54B3-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B54BA-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B54BC-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B54BD-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B54B9-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B54B8-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B54BB-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B54A9-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B54B6-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B54B7-363D-11E5-9242-09173F13E4C5